Vamil Divan

Work Rating Distribution Performance Price Targets & Ratings Chart

Analyst Vamil Divan works at GUGGENHEIM and is focused on the Healthcare sector with 494 price targets and ratings documented since 2013 spanning on 21 stocks. Previously, Vamil Divan worked at MIZUHO, CREDIT SUISSE. Analyst's average stock valuation to be materialised ratio is 65.68% with an average time for price targets to be met of 209.75 days.

Most recent stock forecast was given on ABBV, AbbVie Inc at 01-Mar-2023.

Vamil Divan best performing recommendations are on KRTX (KARUNA THERAPEUTICS, INC).
The best stock recommendation documented was for KRTX (KARUNA THERAPEUTICS, INC) at 8/9/2022. The price target of $276 was fulfilled within 3 days with a profit of $47.55 (20.81%) receiving and performance score of 69.38.

Average potential price target upside

of $48.7 (45.03%) on KRTX (KARUNA THERAPEUTICS, INC).
of $33.55 (28.7%) on JNJ (JOHNSON & JOHNSON).
of $26.47 (12.45%) on LLY (ELI LILLY AND COMPANY).

Currently, out of the existing stock ratings of Vamil Divan - 10903 which are a Hold (35.22%), 19242 which are a Buy (62.15%), 816 which are a Sell (2.64%)